PetMed Express, Inc. PETS
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- -62.81%
- 1 year
- -52.78%
- Open
- 1.17
- Prev close
- 1.18
- Mkt cap
- 25.80M
- Vol
- 42.35K
- Avg vol
- 110.68K
- EPS
- -1.38
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.17
- High
- 1.20
- Forward P/E
- -161.67
- Beta
- 0.68
- Short ratio
- 3.46
- Inst. own
- 47.79%
- Dividend
- 0.00
- Ex-div date
- Aug 10, 2023
- 50-d avg
- 4.77
- 200-d avg
- 4.19
- 1y target
- 3.75
Key statistics
- Market cap
- 100.22M
- Enterprise value
- 51.73M
- Trailing P/E
- 0.00
- Forward P/E
- -161.67
- PEG ratio
- 0.00
- Price / sales
- 0.39
- Price / book
- 1.04
- EPS (TTM)
- -0.06
- Beta
- 0.68
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -0.37%
- Revenue (TTM)
- 259.34M
- Revenue growth
- -16.10%
- Free cash flow
- 20.24M
- Total cash
- 52.05M
- Total debt
- 1.21M
- Return on equity
- -0.92%
- Shares outstanding
- 20.66M
- Short % of float
- 5.71%
- 50-day average
- 4.77
- 200-day average
- 4.19
Analyst view
Consensus: none
- Target (low)
- 3.50
- Target (mean)
- 3.75
- Target (high)
- 4.00
- Strong buy0
- Buy0
- Hold1
- Sell1
- Strong sell0
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 6, 2024 | Sep 1, 2024 | -0.06 | 0.11 | +0.17 | +283.33% |
| Aug 6, 2024 | Jun 1, 2024 | -0.12 | 0.18 | +0.30 | +250.00% |
| Jun 11, 2024 | Mar 1, 2024 | 0.00 | -0.25 | — | — |
| Oct 30, 2023 | Sep 1, 2023 | 0.18 | 0.00 | — | — |
| Jul 31, 2023 | Jun 1, 2023 | 0.09 | 0.00 | — | — |
| May 22, 2023 | Mar 1, 2023 | 0.15 | 0.04 | -0.11 | -73.33% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 7, 2024 | Lake Street | down | Buy | Hold |
| Jun 12, 2024 | Lake Street | main | Buy | Buy |
| Jun 12, 2024 | Morgan Stanley | main | Underweight | Underweight |
| Nov 16, 2023 | Morgan Stanley | main | Underweight | Underweight |
| Oct 31, 2023 | Morgan Stanley | main | Underweight | Underweight |
| Oct 19, 2023 | Morgan Stanley | main | Underweight | Underweight |
About PetMed Express, Inc.
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Country
- United States
- Website
- 1800petmeds.com
News
- PetMed Express, Inc. to Report Second Quarter Fiscal Year 2027 Financial Results on Tuesday, November 10, 2026
- PetMeds Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $1.4
- PetMeds Enhances Board of Directors with Appointment of Tamar Elkeles as New Independent Director
- PetMeds Appoints Jeff Willard as CEO & President and Announces Board Leadership Transition
- PetMeds Appoints Andrew Parry as Chief Technology Officer
- Head-To-Head Contrast: PetMed Express (NASDAQ:PETS) versus Carvana (NYSE:CVNA)
- 12 Consumer Discretionary Stocks Moving In Monday's After-Market Session
- PetMed Express Q1 Earnings Miss Estimates, Sales Decline Y/Y
- PetMed (PETS) Reports Q1 Loss, Misses Revenue Estimates
Your note
Sign in to keep a note on PETS — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CAMPBELL LESLIE C.G | Director | Purchase | Dec 4, 2024 | 0 |
| CAMPOS SANDRA YVETTE | Chief Executive Officer | Stock Award(Grant) | Apr 28, 2024 | 492,215 |
| CHAMBERS CHRISTINE | Chief Financial Officer | Stock Award(Grant) | May 15, 2024 | 106,488 |
| D'ELIA ROBYN M | Chief Financial Officer | Stock Award(Grant) | Sep 26, 2024 | 250,000 |
| FULGONI GIAN M | Director | Stock Award(Grant) | Aug 7, 2024 | 124,510 |
| MENNEN JUSTIN L. | Director | Stock Award(Grant) | Aug 7, 2024 | 8,873 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Renaissance Technologies, LLC | 6.31% | 1,303,269 | 6.32M | Sep 29, 2024 |
| Hotchkis & Wiley Capital Management, LLC | 5.28% | 1,090,703 | 5.29M | Sep 29, 2024 |
| Vanguard Group Inc | 5.23% | 1,080,275 | 5.24M | Sep 29, 2024 |
| Federated Hermes, Inc. | 2.93% | 606,420 | 2.94M | Sep 29, 2024 |
| Blackrock Inc. | 2.73% | 564,458 | 2.74M | Sep 29, 2024 |
| Oaktop Capital Management II, L.P. | 2.11% | 435,844 | 2.11M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.10% | 640,080 | 3.10M | Sep 29, 2024 |
| Federated Hermes MDT Small Cap Core Fund | 2.66% | 550,634 | 2.67M | Jul 30, 2024 |
| Hotchkis and Wiley Small Cap Diversified Value Fund | 1.64% | 338,500 | 1.64M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 1.49% | 308,394 | 1.50M | Sep 29, 2024 |
| Principal Small Cap Value Fd II | 1.29% | 266,783 | 1.29M | Jul 30, 2024 |
| Schwab Strategic Tr-Schwab Fundamental U.S. Small Company Index ETF | 1.16% | 239,287 | 1.16M | Aug 30, 2024 |